A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer
Clinical trial NCT06612151 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06612151
- Sponsor
- MediLink Therapeutics (Suzhou) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-17
- Primary completion
- 2027-12-01
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.